Corvus Pharmaceuticals, Inc.

SUSQUEHANNA INTERNATIONAL GROUP, LLP CRVS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

61,754

Value ($000)

476

Weight

0.0%

2019 Q4 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	476	0.0%	61,754	12/31/2025
2025 Q2	8/14/2025	271	0.0%	67,816	6/30/2025
2025 Q1	5/14/2025	3,025	0.0%	951,343	3/31/2025
2024 Q4	2/14/2025	5,431	0.0%	1,015,083	12/31/2024
2024 Q3	11/14/2024	1,156	0.0%	218,962	9/30/2024
2024 Q2	8/15/2024	47	0.0%	25,650	6/30/2024
2024 Q1	5/7/2024	187	0.0%	105,026	3/31/2024
2023 Q4	2/14/2024	388	0.0%	220,296	12/31/2023
2023 Q3	11/14/2023	187	0.0%	127,968	9/30/2023
2023 Q2	8/11/2023	447	0.0%	195,252	6/30/2023
2023 Q1	5/16/2023	10	0.0%	10,443	3/31/2023
2022 Q1	5/16/2022	79	0.0%	48,283	3/31/2022
2021 Q4	2/14/2022	182	0.0%	75,718	12/31/2021
2021 Q3	11/15/2021	427	0.0%	88,297	9/30/2021
2021 Q2	8/11/2021	95	0.0%	35,706	6/30/2021
2021 Q1	5/17/2021	281	0.0%	91,238	3/31/2021
2020 Q4	2/16/2021	56	0.0%	15,681	12/31/2020
2020 Q1	5/15/2020	248	0.0%	117,606	3/31/2020
2019 Q4	2/14/2020	369	0.0%	67,906	12/31/2019